Clinical, Event FHC Sponsoring WIRED: Epilepsy & DBS Mar 07, 2024 FHC, Inc. and NeuraLynx (an FHC Company) Will be sponsoring and exhibiting at the Third Edition of WIRED (Workshop...
Education, News FHC’s Communities Education Foundation (CEF) now accepting 2024 Spring Scholarship Applications Jan 03, 2024 FHC’s Communities Education Foundation is now accepting applications for the Spring 2024 academic term. Founded in 2010, the FHC...
Clinical, Event FHC and NeuraLynx Exhibiting at AES Dec 01, 2023 FHC, Inc. and NeuraLynx (an FHC Company), will be exhibiting at AES’s Annual Meeting December 1st through the 5th at...
Event, Research FHC and NeuraLynx will be Exhibiting at SfN Nov 08, 2023 FHC, Inc. and NeuraLynx an FHC Company, will be exhibiting at Neuroscience 2023 November 12th through the 15th at...
Clinical, News, Research New NeuraLynx Website Launch Sep 06, 2023 After the acquisition of Neuralynx into FHC’s family of brands, we are launching a new Neuralynx website! This rebuilt...
Clinical, Event FHC Exhibiting at ESSFN Aug 16, 2023 FHC, Inc. will be exhibiting at the 25th Congress of the European Society for Stereotactic and Functional Neurosurgery in...
Education, Event 2023 IONM Course Scheduled for September 22nd – 25th Jul 10, 2023 Knowledge + skill through professional development Many neurological disorders have proven remarkably responsive to Deep Brain Stimulation (DBS) and...
Event, News FHC Sponsoring Dr. Benabid Exhibit In France Jun 02, 2023 A number of surgeons, neuroscientists, and industry leaders are set to gather for the first annual DBS Society conference...
Clinical, News New Guideline 5 Software Update Mar 31, 2023 The Guideline 5 software update to version 2.2.0 includes minor enhancements and bug fixesincluding the following: Power Spectral...
News We Value Your Feedback Jan 09, 2023 We would love to hear about your recent experience with our products. Can you answer three questions to help...